Latest Form 4 insider transactions

Jessica K Norman, See Remarks of Tanger Inc., reported a transaction in 2,889 shares of common stock on October 2, 2026.

Elizabeth Mora, a Director of Allbirds, Inc., received 57,306 shares of common stock on October 1, 2026.

Daniel Martin Kasun, a Director of Allbirds, Inc., received 57,306 shares of common stock on October 1, 2026.

Carlo Calabria, a Director of Arqit Quantum Inc., reported multiple transactions in common stock on October 1, 2026.

Charles A. Ruffel, a Director of Schwab Charles Corp, received 1,222 shares of common stock on October 1, 2026.

Paul Feenan, Chief Revenue Officer of Arqit Quantum Inc., reported multiple transactions in common stock on October 1, 2026.

Andrew Leaver, Chief Executive Officer of Arqit Quantum Inc., reported multiple transactions in common stock on October 1, 2026.

D'Ovidio Manfredi Lefebvre, a Director of Arqit Quantum Inc., reported multiple transactions in common stock on October 1, 2026.

Nicholas William Nilan, General Manager-US of Arqit Quantum Inc., reported multiple transactions in common stock on October 1, 2026.

Garth Ritchie, a Director of Arqit Quantum Inc., reported multiple transactions in common stock on October 1, 2026.

Ben Simon Wilder, Chief Operating Officer of Arqit Quantum Inc., reported multiple transactions in common stock on October 1, 2026.

Patrick Willcocks, General Counsel of Arqit Quantum Inc., reported multiple transactions in common stock on October 1, 2026.

Riad Hussein El-Dada, Former Director of Klotho Neurosciences, Inc., sold 3,500 shares of common stock on October 1, 2026 for $9.35 per share.

Ryan Jay Smith, COO of Algorhythm Holdings, Inc., received 2,119,542 shares of common stock on September 15, 2026.

Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp, sold 35,643 shares of common stock on October 1, 2026.

Francis Lo, Chief People Officer of Adaptive Biotechnologies Corp, sold 26,792 shares of common stock on October 1, 2026.

Corbin Barnes, SVP, Corporate Dev and IR of Innospec Inc., received 2,642 shares of common stock on October 1, 2026.

Hardy Louis Griffin Iii, SVP, HUMAN RESOURCES of Innospec Inc., received 2,685 shares of common stock on October 1, 2026.

Lauren Elaina Friedman Stat, a Director of Palantir Technologies Inc., sold 1,337 shares of common stock on October 1, 2026 for $189.95 per share.

Sameer K Gandhi, a Director of CrowdStrike Holdings, Inc., sold 54,000 shares of common stock on October 1, 2026.

Anurag Saha, CHIEF ACCOUNTING OFFICER of CrowdStrike Holdings, Inc., sold 24,776 shares of common stock on October 1, 2026.

Frank C Herringer, a Director of Schwab Charles Corp, received 445 shares of common stock on October 1, 2026.

Michael S Williams, Chief Executive Officer and a Director of Metallus Inc., sold 12,430 shares of common stock on October 5, 2026 for $20.29 per share.

Kristine C Syrvalin, EVP General Counsel of Metallus Inc., sold 5,000 shares of common stock on October 5, 2026 for $21.12 per share.

William Porteous, a Director of Spire Global, Inc., received 2,818 shares of common stock on October 1, 2026.

Peter Platzer, Executive Chairman and a Director of Spire Global, Inc., sold 17,954 shares of common stock on October 1, 2026 for $11.02 per share.

Roberto Wandenkolk Vieira, President, Oncology of Corcept Therapeutics Inc, sold 8,333 shares of common stock on October 2, 2026.

Michael George Rosenbaum, Chief Executive Officer and a Director of Guidewire Software, Inc., sold 1,200 shares of common stock on October 5, 2026 for $152.52 per share.

Ian Cleminson, EVP & CFO of Innospec Inc., received 4,792 shares of common stock on October 1, 2026.

Peter J Bragdon, President of Columbia Sportswear Co, reported multiple transactions in common stock on October 1, 2026.